Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation
A T50I substitution in the K-Ras interswitch domain causes Noonan syndrome and emerged as a third-site mutation that restored the in vivo transforming activity and constitutive MAPK pathway activation by an attenuated KrasG12D,E37G oncogene in a mouse leukemia model. Biochemical and crystallographic...
Main Authors: | Pan-Yu Chen, Benjamin J. Huang, Max Harris, Christopher Boone, Weijie Wang, Heidi Carias, Brian Mesiona, Daniela Mavrici, Amanda C. Kohler, Gideon Bollag, Chao Zhang, Ying Zhang, Kevin Shannon |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2023-09-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.168445 |
Similar Items
-
KRAS insertion mutations are oncogenic and exhibit distinct functional properties
by: Yasmine White, et al.
Published: (2016-02-01) -
KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation
by: Timothy H. Tran, et al.
Published: (2021-02-01) -
Developing SHP2-based combination therapy for KRAS-amplified cancer
by: Tianxia Li, et al.
Published: (2023-02-01) -
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas
by: Marina Salmón, et al.
Published: (2023-04-01) -
The quaternary assembly of KRas4B with Raf-1 at the membrane
by: Hyunbum Jang, et al.
Published: (2020-01-01)